Terry J. Rosen serves as Executive at Arcus Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Terry J. Rosen has executed 54 insider transactions totaling $5.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 10, 2018 involved purchasing 2,550 shares valued at $30.4K.
Terry J. Rosen currently holds 315,000 shares of Arcus Biosciences, Inc. (RCUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Terry J. Rosen has been a net buyer of RCUS stock. They have purchased $3.5M and sold $2.2M worth of shares.
Terry J. Rosen's most recent insider trade was on Aug 10, 2018, when they purchased 2,550 shares at $11.94 per share.
Get notified when new Form 4 filings are submitted
| $11.92 |
| Discretionary |
| Mar 19, 2018 | RCUS | $0 | Conversion | 2,475,654 | $N/A | Discretionary |
| Mar 19, 2018 | RCUS | $1000.0K | Purchase | 66,666 | $15.00 | Discretionary |